WVE Q4 2024 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$84M+188.2% YoY

Gross Profit

$84M100.0% margin

Operating Income

$23M27.4% margin

Net Income

$29M34.9% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

+1191.0%

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$44M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$352M

Total Liabilities

$143M

Stockholders' Equity

$210M

Cash & Equivalents

$302M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$29M	+188.2%
Gross Profit	$84M	$27M	+211.6%
Operating Income	$23M	-$19M	+222.9%
Net Income	$29M	-$16M	+280.0%